Early-onset Alzheimer's disease (Alzheimer's disease that starts before age 65.
Late-onset Alzheimer's disease (Alzheimer's disease that starts after age 65.
<em>The development of Alzheimer’s vaccine (https://www.creativebiomart.net/alzheimacy/therapeutics/vaccine/) primarily aims at two targets, amyloid beta (Aβ) and tau protein. Their accumulation during Alzheimer’s disease (AD) progression can cause neuronal damage. Therefore, researchers hope that the immune system is able to recognize the antigenic characteristics of the two proteins and produce antibodies against them.</em>
